What Led to the DURAGESIC® Patch Recall?
Since Janssen Pharmaceutica Products, L.P., a company owned by Johnson & Johnson, recalled the DURAGESIC® Patch in April 2004, our lawyers in Arizona have continued to pursue justice for those affected by its potentially life-threatening side effects. The patch was originally designed to deliver a carefully measured dose of fentanyl, a DEA Schedule II narcotic, directly into the bloodstream. However, it was found to have a potentially faulty seal that could result in the leakage of large amounts of the drug. If a faulty DURAGESIC® Patch is applied to the skin, an excessive amount of the strong narcotic could lead to an overdose resulting in varied symptoms.
